347 related items for PubMed ID: 12546339
1. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D.
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
[Abstract] [Full Text] [Related]
2. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
Wilson AM, McFarlane LC, Lipworth BJ.
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
[Abstract] [Full Text] [Related]
3. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis.
Tripathy I, Levy A, Ratner P, Clements D, Wu W, Philpot E.
Pediatr Allergy Immunol; 2009 May; 20(3):287-94. PubMed ID: 19175889
[Abstract] [Full Text] [Related]
4. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J, Caldwell MF, Wolthers OD.
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[Abstract] [Full Text] [Related]
5. Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers.
Bachert C, Lukat KF, Lange B.
Clin Exp Allergy; 2004 Jan; 34(1):85-90. PubMed ID: 14720267
[Abstract] [Full Text] [Related]
6. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis.
Nayak AS, Ellis MH, Gross GN, Mendelson LM, Schenkel EJ, Lanier BQ, Simpson B, Mullin ME, Smith JA.
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):157-62. PubMed ID: 9500747
[Abstract] [Full Text] [Related]
7. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E.
Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
[Abstract] [Full Text] [Related]
8. Intranasal triamcinolone and growth velocity.
Skoner DP, Berger WE, Gawchik SM, Akbary A, Qiu C.
Pediatrics; 2015 Feb; 135(2):e348-56. PubMed ID: 25624374
[Abstract] [Full Text] [Related]
9. Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis.
Gross G, Jacobs RL, Woodworth TH, Georges GC, Lim JC.
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):56-62. PubMed ID: 12141721
[Abstract] [Full Text] [Related]
10. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT, Rabinovitch N, Uryniak T, Simpson B, O'Dowd L, Casty F.
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[Abstract] [Full Text] [Related]
11. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension.
Weinstein S, Qaqundah P, Georges G, Nayak A.
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):339-47. PubMed ID: 19441606
[Abstract] [Full Text] [Related]
12. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML, Menzies D, Nair AR, Hopkinson PJ, Lipworth BJ.
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[Abstract] [Full Text] [Related]
13. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
Bachert C, El-Akkad T.
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
[Abstract] [Full Text] [Related]
14. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
Vargas R, Dockhorn RJ, Findlay SR, Korenblat PE, Field EA, Kral KM.
J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
[Abstract] [Full Text] [Related]
15. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
Stokes M, Amorosi SL, Thompson D, Dupclay L, Garcia J, Georges G.
Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
[Abstract] [Full Text] [Related]
16. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM, McFarlane LC, Lipworth BJ.
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[Abstract] [Full Text] [Related]
17. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
Meltzer EO, Rickard KA, Westlund RE, Cook CK.
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
[Abstract] [Full Text] [Related]
18. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate.
Agertoft L, Pedersen S.
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e199-205. PubMed ID: 19320851
[Abstract] [Full Text] [Related]
19. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.
Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
[Abstract] [Full Text] [Related]
20. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray.
Murphy K, Uryniak T, Simpson B, O'Dowd L.
Ann Allergy Asthma Immunol; 2006 May; 96(5):723-30. PubMed ID: 16729787
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
